Functional Medicine Autoimmune Disease Treatments Treating Autoimmune Disease by Reducing Inflammation Systemic inflammation represents a central driver of autoimmune disease progression and symptom intensity
This dual effect on both sides of the energy balance equation is why retatrutide produced the highest weight loss percentages of any single-agent trial
In rodents and humans, Delta sleep-inducing peptide (DSIP) influence in the secretion of adrenocorticotropic hormone (ACTH), luteinizing hormone (LH) and growth hormone (GH)
Approved sleep medications (melatonin, doxepin, lemborexant) have larger and better-controlled trials than DSIP
Anaphylactoid reactions (i.e., acute hypersensitivity reactions such as rash, hypotension, wheezing, and/or dyspnea) have been reported in patients receiving IV acetylcysteine for the treatment of acetaminophen overdosage